The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 22, 2018

Filed:

Dec. 28, 2015
Applicant:

Astrazeneca Ab, Sodertalje, SE;

Inventors:

Stephen Connolly, Mölndal, SE;

Mark Richard Ebden, Cheshire, GB;

Iain Alastair Stewart Walters, Cheshire, GB;

Thomas Langer, Cheshire, GB;

Alan Robert Steven, Cheshire, GB;

Craig Robert Stewart, Cheshire, GB;

Paula Margaret Tomlin, Cheshire, GB;

Andrew John Williams, Cheshire, GB;

Assignee:

ASTRAZENECA AB, Sodertalje, SE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/506 (2006.01); C07D 403/12 (2006.01); C07C 69/92 (2006.01); C07D 205/04 (2006.01); C07D 317/20 (2006.01); C07D 317/24 (2006.01); C07D 239/56 (2006.01); C07C 65/21 (2006.01); C07D 317/18 (2006.01); C07D 317/26 (2006.01); C07D 307/12 (2006.01); C07C 69/78 (2006.01);
U.S. Cl.
CPC ...
C07D 403/12 (2013.01); A61K 31/506 (2013.01); C07C 65/21 (2013.01); C07C 69/92 (2013.01); C07D 205/04 (2013.01); C07D 239/56 (2013.01); C07D 317/18 (2013.01); C07D 317/20 (2013.01); C07D 317/24 (2013.01); C07D 317/26 (2013.01); C07C 69/78 (2013.01); C07D 307/12 (2013.01);
Abstract

There is provided a compound which is (a) a pyrimidine sulfonamide of formula (I) or (b) a pharmaceutically acceptable salt thereof, crystalline forms of the compound, processes for obtaining the compound, pharmaceutical intermediates used in the manufacture of the compound, and pharmaceutical compositions containing the compound. The compound is useful in the treatment of a disease/condition in which modulation of chemokine receptor activity is beneficial.


Find Patent Forward Citations

Loading…